Xeris Biopharma Holdings (XERS) Debt to Equity (2023 - 2026)
Xeris Biopharma Holdings (XERS) reported Debt to Equity of $17.0 for Q1 2026, up 359.95% on a YoY basis from $3.7 in Q1 2025, and up 5.64% quarter-over-quarter from $16.1 in Q4 2025.
Xeris Biopharma Holdings (XERS) Debt to Equity (2023 - 2026) Analysis & Trends
Xeris Biopharma Holdings has reported Debt to Equity for 4 years, with the latest figure at $17.0 in Q1 2026.
- For the quarter ending Q1 2026, Debt to Equity rose 359.95% year-over-year to $17.0; the trailing twelve-month figure through Mar 2026 stood at $17.0 (up 359.95% YoY), and the FY2025 full-year result was $16.1, up 305.37% from the prior year.
- Debt to Equity for Q1 2026 stood at $17.0, up from $16.1 in the prior quarter.
- The five-year high for Debt to Equity was $17.0 in Q1 2026, with the low at -$254.9 in Q3 2025.
- Historically, Debt to Equity has averaged -$22.46 across 4 years, with a median of -$0.07 in 2024.
- Annual changes were most pronounced in 2025 — Debt to Equity sank 51905.27% — and 2026, when it jumped 359.95%.
- Xeris Biopharma Holdings' Debt to Equity stood at -$28.15 in 2023, then soared by 72.16% to -$7.84 in 2024, then soared by 305.37% to $16.1 in 2025, then climbed by 5.64% to $17.0 in 2026.
- The last three Debt to Equity figures came in at $17.0 (Q1 2026), $16.1 (Q4 2025), and -$254.9 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.02 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.80 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.01 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.61 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.86 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.47 |
| 10 | Xeris Biopharma Holdings | 1.11 Bn | 994.95 Mn | 72.55 Mn | 17.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.00 |
| Dec 31, 2025 | 16.10 |
| Sep 30, 2025 | -254.90 |
| Jun 30, 2025 | -11.33 |
| Mar 31, 2025 | -6.54 |
| Dec 31, 2024 | -7.84 |
| Jun 30, 2024 | -0.02 |
| Mar 31, 2024 | -0.11 |
| Dec 31, 2023 | -28.15 |
| Sep 30, 2023 | 4.53 |
| Jun 30, 2023 | 1.22 |
| Mar 31, 2023 | 0.50 |